Hans Eiskjaer
Hans Eiskjaer
Professor in Cardiology, Aarhus University
Verificeret mail på rm.dk
Citeret af
Citeret af
Defibrillator implantation in patients with nonischemic systolic heart failure
L Køber, JJ Thune, JC Nielsen, J Haarbo, L Videbæk, E Korup, G Jensen, ...
New England Journal of Medicine 375 (13), 1221-1230, 2016
Atlas of the clinical genetics of human dilated cardiomyopathy
J Haas, KS Frese, B Peil, W Kloos, A Keller, R Nietsch, Z Feng, S Müller, ...
European heart journal 36 (18), 1123-1135, 2015
Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients
R Nielsen, N Møller, LC Gormsen, LP Tolbod, NH Hansson, J Sorensen, ...
Circulation 139 (18), 2129-2141, 2019
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial
R Gervais, C Leclercq, A Shankar, S Jacobs, H Eiskjær, A Johannessen, ...
European journal of heart failure 11 (7), 699-705, 2009
Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure
UC Hoppe, JM Casares, H Eiskjær, A Hagemann, JGF Cleland, ...
Circulation 114 (1), 18-25, 2006
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and …
PD Jensen, FT Jensen, T Christensen, H Eiskjær, U Baandrup, JL Nielsen
Blood 101 (11), 4632-4639, 2003
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
M Halbirk, H Nørrelund, N Møller, JJ Holst, O Schmitz, R Nielsen, ...
American Journal of Physiology-Heart and Circulatory Physiology 298 (3 …, 2010
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial
NJ Udesen, JE Møller, MG Lindholm, H Eiskjær, A Schäfer, N Werner, ...
American heart journal 214, 60-68, 2019
Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study
NH Andersen, PL Poulsen, ST Knudsen, SH Poulsen, H Eiskjær, ...
Diabetes care 28 (2), 273-277, 2005
Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure
MB Elming, JC Nielsen, J Haarbo, L Videbæk, E Korup, J Signorovitch, ...
Circulation 136 (19), 1772-1780, 2017
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial
L Gullestad, M Iversen, SA Mortensen, H Eiskjær, GC Riise, L Mared, ...
Transplantation 89 (7), 864-872, 2010
Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate …
NH Andersen, SH Poulsen, H Eiskjaer, PL Poulsen, CE Mogensen
Clinical Science 105 (1), 59-66, 2003
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial
AK Andreassen, B Andersson, F Gustafsson, H Eiskjaer, G Rådegran, ...
American journal of transplantation 14 (8), 1828-1838, 2014
Renal effects of brain natriuretic peptide in patients with congestive heart failure
Clinical science 96 (1), 5-15, 1999
Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international …
M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ...
European Journal of Heart Failure 21 (7), 921-929, 2019
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
F Domínguez, S Cuenca, Z Bilińska, R Toro, E Villard, R Barriales-Villa, ...
Journal of the American College of Cardiology 72 (20), 2471-2481, 2018
Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment
C Aalkjær, H Eiskjær, MJ Mulvany, B Jespersen, T Kjært, SSS Sorensen, ...
Journal of hypertension 7 (4), 305-310, 1989
Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study
AK Andreassen, B Andersson, F Gustafsson, H Eiskjaer, G Rådegran, ...
American Journal of Transplantation 16 (4), 1238-1247, 2016
Effect of everolimus introduction on cardiac allograft vasculopathy—results of a randomized, multicenter trial
S Arora, T Ueland, B Wennerblom, V Sigurdadottir, H Eiskjær, HE Bøtker, ...
Transplantation 92 (2), 235-243, 2011
Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial
L Gullestad, SA Mortensen, H Eiskjær, GC Riise, L Mared, Ø Bjørtuft, ...
Transplantation 90 (12), 1581-1589, 2010
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20